The U.S. Food and Drug Administration (FDA) has approved a label update to Novartis’ Cosentyx (secukinumab),…
Articles by Iqra Mumal, MSc
Poor mental health, not having a full-time job, spending fewer years in school, and having comorbidities such as hypertension or…
People with ankylosing spondylitis (AS) are almost three times more likely to develop obstructive sleep apnea (OSA) than…
People with ankylosing spondylitis (AS) have an altered composition of microorganisms in their gut, leading to more bacteria that…
Qletli, a biosimilar to Humira (adalimumab), is now available in China for the treatment of three autoimmune diseases,…
Despite experiencing similar symptoms, people with non-radiographic axial spondyloarthritis (nr-axSpA) are less likely to be treated with a…
The first ankylosing spondylitis (AS) patient has been dosed in a Phase 3 trial testing SCB-808, a potential biosimilar…
Moxibustion, a form of heat therapy widely used in East Asia, given in combination with conventional treatments may be of…
LINC00311, a type of long non-coding RNA molecule, is overexpressed in patients with ankylosing spondylitis and is associated with worse…
Overall, patients with ankylosing spondylitis (AS) are more likely to develop osteoporosis compared to the general population, a new study…